BioWorld Science

July 21, 1998

View Archived Issues

ZymeTx signs agreement for potential HIV antiviral technology

Read More

Enzo Biochem initiates phase I clinical trials of HIV-1 treatment

Read More

Generex submits IND for Oralin in Canada

Read More

New clinical trial of G-3139 in prostate cancer gets under way at U.S. center

Read More

NeXstar initiates third phase II MiKasome trial

Read More

Increased sexual activity in Muse-treated men does not mean increased risk of CV side effects

Read More

Ribi acquires new adjuvant technology from U of Nebraska

Read More

Promising phase II results reported for BTI-322 in GVHD

Read More

StressGen establishes multiinstitutional collaboration for stress protein-modulating drugs

Read More

Arylureas and arylmethylcarbamoyl derivatives as ACAT inhibitors

Read More

Antimetastatic antibiotic isolated from Penicillium at Takara Shuzo

Read More

Potent, broad-spectrum antibacterial compounds developed at Daiichi

Read More

Yoshitomi prepares agents for hyperuricemia and gout

Read More

Antifungal series emerges from R&D at Pola

Read More

Profile of the second-generation alkylphosphocholine perifosine

Read More

RiboGene receives additional funding in the area of antifungals

Read More

Altana offer to license Solarase accepted by Hyal

Read More

Joint development agreement for Hyanalgese-D announced by Hyal

Read More

Xoma now owns or has exclusive rights to all BPI-related patents

Read More

Restless legs syndrome: description and treatment options

Read More

Hypnotic effects of the benzodiazepine receptor ligand SX-3228 in rats

Read More

Calcium channel blockers reduce craving for alcohol

Read More

SIB-1553A goes head-to-head with established cognition-enhancing drugs

Read More

HMR arthritis Rx up for FDA committee review

Read More

EEG analysis reveals the atypical antipsychotic profile of OPC-14597

Read More

New indication explored for established anticonvulsant

Read More